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respirator for health care workers participating in
aerosol-generatingprocedures.Thus, it is essential thatall
providers and staff who are participating in procedures
located on mucosal regions be provided with an N95,
especially if aerosols are generated with electrocautery.4
To take further precaution, we also suggest that patients
having procedures performed in mucosal regions be
tested for COVID-19 before their visit. It is our hope that
this letter raises awareness of the potential harmful effects
of surgical smoke to spur further insights and action
regarding preventativemeasures for resuming outpatient
dermatologic procedures in the age of COVID-19.
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N95 Respirators for Dermatologic Surgery and Laser Procedures During COVID-19 and Beyond
The SARS-CoV-2 (COVID-19) pandemic brought
personal protective equipment (PPE) to the forefront
of medicine. Although surgical masks are consistently
used in dermatologic surgery, N95 filtering facepiece
respirators (FFRs) have not been widely used. Some
recommendations exist, but no official guidelines dis-
cuss facial protection with N95 respirators for Mohs
micrographic surgery (MMS) or other dermatologic
surgery including ablative lasers. Because of the cur-
rent pandemic, close proximity of many of these pro-
cedures to the orofacial region and the increased risk
for exposure to chemical irritants generated as a result
of electrocoagulation or laser ablation, it is imperative
that physicians and surgeons understand current evi-
dence and knowledge gaps.
Dermatologic surgeryhas inherent risks, includingneedle
sticks, smoke inhalation, splash injury, and viral trans-
mission. Electrocoagulation and laser ablation generate a
surgical plume, which poses a significant risk as a respi-
ratory tract irritant, mutagen, and vector for infectious
particles.1 Chemicals generated from surgical plume,
such as nitriles and hydrogen cyanide, have been shown
to have carcinogenic and mutagenic effects in vitro indi-
cating the need for adequate protection during these
dermatologic surgery.1 Surgical plume also acts as a
vector for viral transmission, with dense laser ablative
smoke containing higher viral DNA content than elec-
trocoagulation smoke.1 Human papillomavirus (HPV)
andHIV are transmissible in surgical plume, and the use
of high efficiency air respirators alongside a smoke
evacuator 1 inch away from any dermatologic surgery
generating adequate smoke plume is recommended.1
Smoke evacuators capture and filter surgical plume dur-
ing electrosurgical or laser procedures, minimizing
exposure of the health care professionals and patients to
harmful contaminants.1
Surgicalmasksofferprotectionagainstparticulatematter
size greater than 5 mm, with a filtration efficiency of
91.53%.1 However, most surgical smoke contains par-
ticulatematter less than5mmand thus requires increased
filtration capacity.1 Biologic material in smoke can range
in size, with the COVID-19 virus reported to be
0.06–0.14 mm, comparable with the size of influenza
virus, whereas HIV and HPV are 0.12 and 0.055 mm,
respectively.2 N95 FFRs offer more effective protection
from harmful particles generated from surgical smoke
and infectious particles as they can filter submicrometer-
sized particles and are designed to allow no more than
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5% penetration.3 The previous literature has established
improved protection from surgical smoke with N95
FFRs compared with standard surgical masks.3 These
data were quantified as simulated workplace protection
factor (SWPF) by comparing the aerosol concentrations
and particle distribution inside and outside the mask.
Results outlined essentially no protection from surgical
smoke while wearing a surgical mask and a statistically
significant improvement in SWPF when wearing N95
FFRs compared with the surgical mask.3 Therefore, a
properly fitted N95 FFR offers superior protection from
residual plume generated from electrosurgical or laser
procedures in the absence of smoke evacuator use. In
addition,N95 respirators have demonstrated superiority
over surgicalmasks inprotection fromviral transmission.
A recent systematic reviewwithmeta-analysis also found
that facemask use could result in a large reduction in risk
of COVID-19 infection (aOR 0.15, 95% confidence
interval 0.07–0.34), and increased benefit with N95 res-
pirators was seen when compared with surgical masks
(pinteraction = 0.090; posterior probability >95%).4
Most current national and international guidelines
include the use of an N95 respirator for all aerosol-
generating procedures involving patients with COVID-
19, although inconsistencies exist. COVID-19 can be
spread by talking or exhaling, but risk of transmission
while wearing a surgical mask is under debate. The
American College of Surgeons groups electro-
coagulation of blood with other aerosol generating
procedures and requires the use of full PPE, including an
N95 or a similar respirator, when performing such
procedures. The American Academy of Otolaryngology
recommends limiting nonessential surgeries and the
mandatoryuseofN95FFRs forall procedures that cause
aerosolization. Similar recommendations have been
made by the American Dental Association. Recom-
mendations for dermatologic surgery and laser proce-
dures during this pandemic include the usage of well-
fitted N95 FFRs for all procedures in close proximity to
the periorificial region.5 Minimum required PPE for
providers and staff involved with an aerosol generating
procedure should include an N95 or equivalent mask,
wraparound safety glasses or full goggles, gloves and a
gown, and if available a surgical cap.5 Additional pre-
cautions for energy-based procedures include a smoke
evacuator system.5 Personal protective equipment con-
siderations are vital for the safety of physicians and staff.
TheuseofN95respirators shouldbe stronglyconsidered
during MMS, particularly when working for extended
periods in the periorificial area, as well as any dermato-
logic procedure which produces a surgical plume
including laser ablation and electrocoagulation when
blood is present, even after the pandemic. It is important
to undergo respirator fit testing to ensure adequate fit of
the respirator and that safe donning and doffing be
practiced to minimize contamination of the respirator
andfingers.Other system safetymeasures include smoke
evacuation and adequate environmental sanitization
protocols. These recommendations are irrespective of
PPEavailability and focus solelyon themedical risk from
smoke inhalation and viral transmission.
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